Tower Research Capital (TRC)’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $481K | Buy |
3,590
+3,165
| +745% | +$424K | 0.01% | 1018 |
|
|
2025
Q1 | $28.6K | Sell |
425
-3,934
| -90% | -$265K | ﹤0.01% | 2658 |
|
|
2024
Q4 | $272K | Buy |
4,359
+4,103
| +1,603% | +$256K | 0.01% | 1491 |
|
|
2024
Q3 | $40.2K | Sell |
256
-4,692
| -95% | -$737K | ﹤0.01% | 2844 |
|
|
2024
Q2 | $745K | Buy |
4,948
+4,501
| +1,007% | +$678K | 0.01% | 1001 |
|
|
2024
Q1 | $33.1K | Sell |
447
-6,136
| -93% | -$454K | ﹤0.01% | 2576 |
|
|
2023
Q4 | $520K | Buy |
6,583
+3,105
| +89% | +$245K | 0.01% | 1338 |
|
|
2023
Q3 | $190K | Buy |
3,478
+2,596
| +294% | +$142K | 0.01% | 1459 |
|
|
2023
Q2 | $74.1K | Buy |
882
+289
| +49% | +$24.3K | ﹤0.01% | 2248 |
|
|
2023
Q1 | $45K | Sell |
593
-3,995
| -87% | -$303K | ﹤0.01% | 2597 |
|
|
2022
Q4 | $283K | Buy |
4,588
+1,985
| +76% | +$122K | 0.01% | 1064 |
|
|
2022
Q3 | $109K | Buy |
2,603
+1,448
| +125% | +$60.6K | ﹤0.01% | 2492 |
|
|
2022
Q2 | $36K | Buy |
1,155
+816
| +241% | +$25.4K | ﹤0.01% | 3196 |
|
|
2022
Q1 | $9K | Sell |
339
-1,843
| -84% | -$48.9K | ﹤0.01% | 4497 |
|
|
2021
Q4 | $41K | Buy |
2,182
+1,776
| +437% | +$33.4K | ﹤0.01% | 2926 |
|
|
2021
Q3 | $13K | Sell |
406
-3,226
| -89% | -$103K | ﹤0.01% | 4102 |
|
|
2021
Q2 | $121K | Sell |
3,632
-1,313
| -27% | -$43.7K | ﹤0.01% | 2279 |
|
|
2021
Q1 | $206K | Buy |
4,945
+2,697
| +120% | +$112K | ﹤0.01% | 1986 |
|
|
2020
Q4 | $45K | Sell |
2,248
-18,987
| -89% | -$380K | ﹤0.01% | 3221 |
|
|
2020
Q3 | $293K | Buy |
21,235
+17,339
| +445% | +$239K | ﹤0.01% | 2210 |
|
|
2020
Q2 | $70K | Buy |
3,896
+514
| +15% | +$9.24K | ﹤0.01% | 2779 |
|
|
2020
Q1 | $41K | Buy |
3,382
+2,804
| +485% | +$34K | ﹤0.01% | 1385 |
|
|
2019
Q4 | $11K | Sell |
578
-3,224
| -85% | -$61.4K | ﹤0.01% | 2296 |
|
|
2019
Q3 | $90K | Sell |
3,802
-2,749
| -42% | -$65.1K | 0.01% | 1421 |
|
|
2019
Q2 | $190K | Buy |
+6,551
| New | +$190K | 0.01% | 874 |
|